GSK2324
GSK2324 is a potent and selective FXR agonist developed for NAFLD/NASH research. It modulates hepatic lipid metabolism by inhibiting fatty acid uptake and synthesis, as demonstrated in both in vitro assays and in vivo rodent models of metabolic disease.
Product Specifications
CAS Number
1020567-30-9
Product Name Alternative
FXR, GSK 2324, GSK2324, GSK-2324
Field of Research
Metabolism Research
Purity
98.09% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:100 mg/mL (187.48 mM)
Smiles
C (OC1=CC=C (C=C1) C2=CC3=C (C=C2) N=C (C (O) =O) C=C3) C=4C (=NOC4C (C) C) C5=C (Cl) C=CC=C5Cl
Molecular Formula
C29H22Cl2N2O4
Molecular Weight
533.4
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx145210-01 100 µg
Zinc Phosphodiesterase ELAC Protein 2 (ELAC2) Antibody
Sign In for Pricing
View Details abx145210-02 1 mg
Zinc Phosphodiesterase ELAC Protein 2 (ELAC2) Antibody
Sign In for Pricing
View Details 
